ARS Pharmaceuticals Eulerpool Uudised

ARS Pharmaceuticals Eulerpool News

ARS Pharmaceuticals aktsia uudised

ARS Pharmaceuticals jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad ARS Pharmaceuticals uudised paneme siia kokku.

• 23. september ·

  Yahoo
  ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
• 23. september ·

  Seeking Alpha
  ARS Pharma launches neffy epinephrine nasal spray in U.S.
• 23. september ·

  GlobeNewswire
  ARS Pharmaceuticals Announces U.S. Availability of neffy? (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
• 19. september ·

  GuruFocus
  ARS Pharmaceuticals Inc (SPRY) Insider Sells Shares
• 11. september ·

  Yahoo
  ARS Pharmaceuticals (SPRY): A Bull Case Theory
• 10. september ·

  Yahoo
  ARS Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference
• 9. september ·

  Yahoo
  ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)
• 9. september ·

  GlobeNewswire
  ARS Pharmaceuticals Submits sNDA to FDA for neffy? 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)
• 7. september ·

  Yahoo
  Insider Returns Down To US$660k As ARS Pharmaceuticals' Stock Dips 12%
• 6. september ·

  Yahoo
  ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's Why